Table 1.
Tuberculosis related examinations and practices in 15 antiretroviral treatment programmes in Africa, Asia and Latin America.
| Characteristic | N | (%) |
|---|---|---|
| Chest X-ray | ||
| Free of charge | 13 | (86.7) |
| At cost to patient | 2 | (13.3) |
|
| ||
| Sputum microscopy | ||
| Free of charge | 14 | (93.3) |
| At cost to patient | 1 | (6.7) |
|
| ||
| Mycobacterial culture | ||
| Free of charge | 8 | (53.3) |
| At cost to patient | 3 | (20.0) |
| Not available | 4 | (26.7) |
|
| ||
| Mycobacterial culture on site | 6 | (40.0) |
|
| ||
| Tuberculin skin test | ||
| Free of charge | 6 | (40.0) |
| Not available | 9 | (60.0) |
|
| ||
| Screening by interferon-based test | ||
| Selected cases | 1 | (6.7) |
| Never / not available | 14 | (93.3) |
|
| ||
| TB DOT | ||
| During the 1st 2 months | 4 | (26.7) |
| During entire treatment period | 4 | (26.7) |
| Not used | 7 | (46.6) |
|
| ||
| TB treatment location | ||
| In HIV clinic | 4 | (26.7) |
| In specialized TB clinic | 11 | (73.3) |
|
| ||
| Isoniazid preventive therapy | ||
| Routinely used | 5 | (33.3) |
| Used when clinically indicated | 3 | (20.0) |
| Not used | 7 | (46.7) |
|
| ||
| TB case definitions used* | ||
| WHO definitive case definition | 11 | (73.3) |
| WHO clinical case definition | 12 | (80.0) |
TB, tuberculosis; WHO, World Health Organization
*
Categories not exclusive